Skip to content
Screener

Chemours CC Titanium Technologies — Research And Development Expense

Other segment segments

Advanced Performance Materials
$12M0.0%
Thermal And Specialized Solutions
$8M+14.3%

Similar metrics at other companies

Novanta logo
NOVTAutomation Enabling Technologies — Research And Development Expense
$9.5M+2.4%
Beam Therapeutics logo
BEAMExternal Research And Development Expenses — Research And Development Expense
$30.08M-12.6%
Bruker logo
BRKREnergy And Supercon Technologies — Research And Development Expense
$1M-9.1%
Viasat logo
VSATDefense And Advanced Technologies — Research And Development Expense
$17.1M+14.0%
Solid Biosciences Inc. logo
SLDBInternal Research And Development Expense — Research And Development Expense
$9.06M+33.9%
Disc Medicine logo
IRONInternal Research And Development — Research And Development Expense
$11.31M+67.6%

Other financials

Income statement

See full
Revenue$1.6B-1.5%
Gross profit$286.0M+2.9%
Net income-$274.0M+27.9%
EPS (diluted)-$1.81+28.5%

Balance sheet

See full
Cash & equivalents$671.0M+33.7%
Total debt$4.2B-6.5%
Total equity-$49.0M-121%
Total assets$7.2B-4.2%

Cash flow

See full
Operating cash flow$158.0M+69.9%
CapEx$44.0M+2.3%
Free cash flow$114.0M

Valuation

See full
Market cap$2.27B+26.6%
Enterprise value$5.76B+0.4%
P/S0.4×+0.1×

Profitability

See full
Gross margin15.3%-2.9pp
Net margin-5.2%-1.2pp
FCF margin5.1%-1.7pp

Returns & leverage

See full
Return on equity-105%-107pp
Debt / equity20.6×+12.8×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Chemours in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Chemours’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 11:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001627223-26-000024
Three Months Ended June 30, 2026Thermal & Specialized SolutionsTitanium TechnologiesAdvanced Performance Materials
Net sales to external customers (1)$591$661$326
Segment cost of goods sold360611289
Segment selling, general and administrative expense302934
Segment research and development expense8712
Add back: Depreciation and amortization (2)183323
Equity in earnings of affiliates36
Other segment items (3)1(1)(6)
Segment Adjusted EBITDA$213$48$26

Item 1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Chemours's titanium technologies — research and development expense?
Chemours (CC) reported titanium technologies — research and development expense of $7M in Q2 2026.
How has Chemours's titanium technologies — research and development expense changed year-over-year?
Chemours's titanium technologies — research and development expense decreased by 12.5% year-over-year, from $8M to $7M.
What is the long-term trend for Chemours's titanium technologies — research and development expense?
Over 4 years (2021 to 2025), Chemours's titanium technologies — research and development expense has grown at a -5.3% compound annual growth rate (CAGR), from $36M to $29M.
What does titanium technologies — research and development expense mean?
Represents the investment made by the Titanium Technologies segment into innovation, product development, and process improvements for titanium dioxide applications. High or increasing levels of R&D spending often signal a commitment to maintaining competitive advantage and long-term product differentiation.

Ask your AI about Chemours's titanium technologies — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude